- Home
- CTSO vs FUSB Comparison
CTSO vs FUSB Comparison
Compare CTSO & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- FUSB
- Stock Information
- Founded
- CTSO 1997
- FUSB 1952
- Country
- CTSO United States
- FUSB United States
- Employees
- CTSO N/A
- FUSB N/A
- Industry
- CTSO Medical/Dental Instruments
- FUSB Major Banks
- Sector
- CTSO Health Care
- FUSB Finance
- Exchange
- CTSO Nasdaq
- FUSB Nasdaq
- Market Cap
- CTSO 57.6M
- FUSB 63.1M
- IPO Year
- CTSO N/A
- FUSB N/A
- Fundamental
- Price
- CTSO $1.03
- FUSB $10.70
- Analyst Decision
- CTSO Strong Buy
- FUSB
- Analyst Count
- CTSO 4
- FUSB 0
- Target Price
- CTSO $4.50
- FUSB N/A
- AVG Volume (30 Days)
- CTSO 68.5K
- FUSB 2.0K
- Earning Date
- CTSO 08-13-2024
- FUSB 10-23-2024
- Dividend Yield
- CTSO N/A
- FUSB 1.87%
- EPS Growth
- CTSO N/A
- FUSB 6.67
- EPS
- CTSO N/A
- FUSB 1.37
- Revenue
- CTSO $37,159,990.00
- FUSB $40,512,000.00
- Revenue This Year
- CTSO $11.03
- FUSB N/A
- Revenue Next Year
- CTSO $18.75
- FUSB N/A
- P/E Ratio
- CTSO N/A
- FUSB $7.81
- Revenue Growth
- CTSO 2.17
- FUSB 3.09
- 52 Week Low
- CTSO $0.70
- FUSB $7.95
- 52 Week High
- CTSO $2.54
- FUSB $11.19
- Technical
- Relative Strength Index (RSI)
- CTSO 50.19
- FUSB 58.47
- Support Level
- CTSO $0.99
- FUSB $10.60
- Resistance Level
- CTSO $1.07
- FUSB $10.98
- Average True Range (ATR)
- CTSO 0.06
- FUSB 0.04
- MACD
- CTSO -0.00
- FUSB -0.00
- Stochastic Oscillator
- CTSO 38.83
- FUSB 51.72
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals and other individuals.